MedPage Today on MSN
Low testosterone may raise risk of 'extreme' prostate cancer progression
Results challenge view that high testosterone fuels prostate cancer growth ...
Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, research has demonstrated that combining ADT with additional agents ...
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...
The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
February 1, 2012 — A new study suggests that vigorous physical activity will offer protection against prostate cancer progression because of its effects on DNA repair and cell-cycle pathways. The ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
But as it turned out, his transition from military service to civilian life came with prostate cancer. It was during his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results